Sort
261,768 grants matching “gene therapy”
Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies
$914,570John F Dipersio · Washington University · R35 · FY2021 · CA
Therapeutic targets in African-American youth with type 2 diabetes
$914,529Stephanie Therese Chung · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Advancing Cancer Therapy through Ground Breaking Research in Radiation Biology
$914,522David G Kirsch · Duke University · R35 · FY2019 · CA
A smart cell drug (SmaCD) delivery platform for mobile, targetable, and self-regulated combination therapy: a model project to rescue antibodies from Alzheimer's disease (AD) clinical trial failures
$914,477Julie Kay Andersen · Buck Institute For Research On Aging · R01 · FY2025 · AG
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer
$914,388Lawrence H Schwartz · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Discovery of Critical Host Genes Enabling Resistance to HIV-1 Infection as Therap
$914,355Leyla S Diaz · Functional Genetics, Inc. · R44 · FY2012 · AI
Computational Analysis of Drug Response in Biological Networks
$914,346Augustin Luna · National Library Of Medicine · ZIA · FY2025 · LM
Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure
$914,341Kory J. Lavine · Washington University · R35 · FY2024 · HL
Molecular Pathogenesis of Acute Myeloid Leukemia
$914,339Timothy J Ley · Washington University · R35 · FY2023 · CA
Prostate Section
$914,335Peter Pinto · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Development of therapeutics for chlorine-induced airway and lung injury
$914,322Michael D Gunn · Duke University · U01 · FY2012 · ES
Next generation hybrid nucleases for precise excision of latent HIV-1 provirus
$914,295Jeremy Luban · Univ Of Massachusetts Med Sch Worcester · R01 · FY2016 · AI
Next generation hybrid nucleases for precise excision of latent HIV-1 provirus
$914,295Jeremy Luban · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · AI
PLK1 and EGFR targeted nanoconstruct as a monotherapy and a radiation sensitizer for lung cancer
$914,249Worapol Ngamcherdtrakul · Pdx Pharmaceuticals, Inc. · R44 · FY2024 · CA
Chromosomal Proteins and Chromosomal Functions
$914,243Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Genomics and Proteomics of Head and Neck Cancer
$914,150Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2021 · DC
eCD4-mediated control of SIV infection in the brain
$914,116Michael R. Farzan · Boston Children'S Hospital · R01 · FY2023 · NS
Clinical, genetic and cardiometabolic risk correlates of the gut microbiome
$914,048Stanley Y Shaw · Broad Institute, Inc. · R01 · FY2016 · HL
Cocaine HIV/AIDS, and Antiretrovirals
$913,956William Lewis · Emory University · R01 · FY2010 · DA
Translational Development of Replication-Competent Retrovirus Vectors
$913,956Noriyuki Kasahara · University Of California Los Angeles · U01 · FY2011 · NS
DICE - a natural cancer surveillance mechanism - a new road to cancer therapy
$913,955Marcus E Peter · Northwestern University At Chicago · R35 · FY2016 · CA
DISE - a natural cancer surveillance mechanism - a new road to cancer therapy
$913,955Marcus E Peter · Northwestern University At Chicago · R35 · FY2017 · CA
DISE - a natural cancer surveillance mechanism - a new road to cancer therapy
$913,955Marcus E Peter · Northwestern University At Chicago · R35 · FY2020 · CA
DISE - a natural cancer surveillance mechanism - a new road to cancer therapy
$913,955Marcus E Peter · Northwestern University At Chicago · R35 · FY2021 · CA
Cellularly resolved molecular pathway assessment in biopsies via spectral imaging
$913,767Clifford C Hoyt · Cambridge Research And Instrumentation · R44 · FY2010 · CA